Company intelligence / Profile preview

Thimble Point Acquisition Corp.

New Haven, Connecticut, United States

Ownership: Private
Development stage: Other

Overview

Thimble Point Acquisition Corp. was a special purpose acquisition company (SPAC) formed to take other companies public via merger. It targeted high-growth tech companies, including those in healthcare, and completed a reverse merger with Pear Therapeutics in December 2021, ceasing independent existence

Industry: Investors

Beyond the preview

Go deeper on Thimble Point Acquisition Corp..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thimble Point Acquisition Corp..

Explore the full profile